Authors
Cecilia Solís-Martín, Ramón Morillo-Verdugo
Published in
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. Sep 08, 2026. Epub Sep 08, 2026.
Abstract
To analyze the concordance between the stratification offered by the tool included in the adaptation of the capability-motivation-opportunity model for patients with cardiovascular diseases developed by De Dios et al. 2025 and that obtained when applying it in clinical practice.
Observational, cross-sectional, single-center study (January-March 2025) which included patients undergoing active treatment with proprotein convertase subtilisin/kexin type 9 inhibitors or inclisiran who attended outpatient hospital pharmacy consultations. The variables collected for stratification were demographic, clinical, pharmacotherapeutic, and socio-health variables. The adapted capacity-motivation-opportunity model in patients with cardiovascular diseases was used for stratification. The Chi-square method for a single sample was used to analyze concordance. The data were processed using the IBM-SPSS v.30 statistical program.
A total of 126 patients were included (median age 63.2 years (IQR = 58.9-72.5); 69.2% men). The percentages obtained were 6.3% (95% CI: 2.1-10.6%) in priority 1, 33.3% (95% CI: 25.1-41.6%) in priority 2, and 60.3% (95% CI: 51.8-68.8%) in priority 3, with theoretical distribution being 10, 30, and 60%, respectively (p = 0.342).
There is agreement between both distributions, which supports the applicability of the tool in healthcare practice, and it can be used to prioritize resources in outpatient consultations.
PMID:
42711237
Bibliographic data and abstract were imported from PubMed on 09 Sep 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0